Company news
Bio-Techne Corp news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Bio-Techne Appoints Rupert Vessey to Board of Directors
June 24, 2019
FDA Grants Breakthrough Device Designation To Bio-Techne's ExoDx(TM) Prostate IntelliScore(TM) (EPI) Test
June 16, 2019
Bio-Techne Receives Approval To Offer The ExoDx(TM) Prostate Intelliscore(TM) (EPI) Test In New York State
June 12, 2019
Bio-Techne To Acquire B-MoGen Biotechnologies Inc.
June 3, 2019
Bio-Techne's New Exosome-Based Liquid Biopsies Helping To Advance Personalized Care In Lung Cancer Diagnostics
May 27, 2019
Bio-Techne To Host Conference Call On April 30, 2019 To Announce Third Quarter 2019 Financial Results
April 8, 2019
Calls
The 5 newest of 27 calls. Every call is listed under its year.
- Bio-techne (NASDAQ:TECH) Q3 2026 Earnings Call
May 6, 2026
Transcript - Bio-techne (NASDAQ:TECH) Q2 2026 Earnings Call
Feb 4, 2026
Transcript - Bio-techne (NASDAQ:TECH) Q1 2026 Earnings Call
Nov 5, 2025
Transcript - Bio-techne (NASDAQ:TECH) Q4 2025 Earnings Call
Aug 6, 2025
Transcript - Bio-techne (NASDAQ:TECH) Q3 2025 Earnings Call
May 7, 2025
Transcript
Decks
The 5 newest of 16 decks. Every deck is listed under its year.
- Investor Presentation (January 2026)
Investor deck · 14 slides · January 2026
- Investor Presentation (June 2025)
Investor deck · 15 slides · Jun 3, 2025
- Investor Presentation (January 2025)
Investor deck · 15 slides · Jan 14, 2025
- Investor Presentation (June 2024)
Investor deck · 26 slides · June 2024
- Investor Presentation (January 2024)
Investor deck · 26 slides · January 2024